S. Cowley

Statistics

Publications

Citations

135

H-Index

Active since

2011

Affiliations

Auckland City Hospital(Current)

S. Cowley is an author at Auckland City Hospital specializing in flt3 inhibitors, cytarabine-based regimens, and hematologic malignancy pharmacotherapy.

ORCID

Publications per year

2011–2024

Publications

Evaluation of safety and human tolerance of the oral probiotic Streptococcus salivarius K12: A randomized, placebo-controlled, double-blind study

Jeremy P. Burton, S. Cowley, Ryan Simon et al. · Food and Chemical Toxicology · 2011 · 94 citations

Life Sciences, Microbiology, Oral Microbiology +11

Fludarabine, Cytarabine, Granulocyte Colony-Stimulating Factor, and Idarubicin With Gemtuzumab Ozogamicin Improves Event-Free Survival in Younger Patients With Newly Diagnosed AML and Overall Survival in Patients With <i>NPM1</i> and <i>FLT3</i> Mutations

Nigel H. Russell, Charlotte S. Wilhelm-Benartzi, Jad Othman et al. · Journal of Clinical Oncology · 2024 · 41 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +15

1–2 of 2